C.H. Robinson to acquire RXO in $5.8 billion stock-and-cash deal
C.H. Robinson agreed on October 4, 2026 to acquire RXO through a merger that the companies value at an implied $5.8 billion. RXO shareholders can elect $17.25 in cash plus 0.0856 C.H. Robinson shares, $30.25 in cash, or 0.1992 C.H. Robinson shares, with proration targeting about 57% cash and 43% stock. The deal is expected to close in the first half of 2027 and requires RXO stockholder approval and regulatory clearance, and C.H. Robinson expects about $300 million of net run-rate cost synergies within two years of closing.
Key points
- Implied value of $5.8 billion; RXO shareholders would own about 11% of the combined company
- Expected net run-rate cost synergies of about $300 million within two years after closing
- C.H. Robinson will fund the cash portion with new debt and has a bridge facility from Morgan Stanley Senior Funding; it plans to pause share repurchases until reaching its target leverage
- RXO would pay a $175 million termination fee in certain circumstances; the outside date is July 4, 2027, subject to two three-month extensions
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:11 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 05, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.